Stocksigma LogoStocksigma Logo

Ajooni Biotech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

■ Revenue: 6,537 (+106.0% YoY | +3.0% QoQ) ■ EBITDA: 202 (+34.4% YoY | +21.0% QoQ) ■ EBITDA Margin (%): 3.1 (-165 bps YoY | +46 bps QoQ) ■ PAT: 51.1

Ajooni Biotech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

Ajooni Biotech Ltd · Outcome · 13 Nov 2026, 6:16 pm

Ajooni Biotech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 6,537 (+106.0% YoY | +3.0% QoQ) ■ EBITDA: 202 (+34.4% YoY | +21.0% QoQ) ■ EBITDA Margin (%): 3.1 (-165 bps YoY | +46 bps QoQ) ■ PAT: 51.1 (-45.2% YoY | +18.3% QoQ) ■ EPS (INR): 0.02 (-75.0% YoY | +100.0% QoQ)

Original exchange filing (PDF)

More announcements from Ajooni Biotech Ltd

All Ajooni Biotech Ltd announcements